Recombinant TSR1 of ADAMTS5 suppresses melanoma growth in mice via an anti-angiogenic mechanism

• Main Authors: Renganathan, B, Durairaj, V, Kirman, D.C, Esubonteng, P.K.A, Ang, S.K, Ge, R
• Other Authors: DEPT OF BIOLOGICAL SCIENCES
• Format: Article
• Published: 2020
• Subjects: aggrecanase 2; angiogenesis inhibitor; antineoplastic agent; caspase 3; recombinant protein; recombinant thrombospondin type 1 repeat; unclassified drug; adult; animal experiment; animal model; antiangiogenic activity; antineoplastic activity; apoptosis; Article; cancer growth; cancer inhibition; cell proliferation; controlled study; drug mechanism; enzyme repression; Escherichia coli; female; human; human cell; human tissue; limit of quantitation; melanoma B16; mouse; nonhuman; umbilical vein endothelial cell
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/175054
• Institution: National University of Singapore

10.3390/cancers10060192